Brain iron uptake and homeostatic mechanisms: An overview

Timely and adequate iron acquisition by the brain is essential to normal neurological function. Despite the numerous cognitive and neurological impairments that are associated with disruptions in brain iron acquisition, including both too much and too little iron, the mechanism and regulation of the mechanisms by which the brain acquires iron are poorly understood. In this article, we review the current state of knowledge regarding expression of iron transport proteins in the brain, brain iron uptake and discuss why a model for brain iron uptake must take into consideration the potentially competing influences on the endothelial cell between the status of iron in the brain versus the systemic iron status.

[1]  K. Dziegielewska,et al.  Comparison of proteins in CSF of lateral and IVth ventricles during early development of fetal sheep. , 1983, Brain research.

[2]  E. Taylor,et al.  Developmental changes in transferrin and iron uptake by the brain in the rat. , 1990, Brain research. Developmental brain research.

[3]  J. Connor,et al.  Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier , 1987, Journal of neuroscience research.

[4]  J. Connor,et al.  Transferrin is required for normal distribution of 59Fe and 54Mn in mouse brain , 1999, Journal of the Neurological Sciences.

[5]  M. Bradbury.  Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System , 1997, Journal of neurochemistry.

[6]  G. Jacobsen,et al.  Immunohistochemical evidence for an intracellular localization of plasma proteins in human foetal choroid plexus and brain , 1979, Neuroscience Letters.

[7]  J. Hoke,et al.  Defective iron uptake and globin synthesis by erythroid cells in the anemia of the Belgrade laboratory rat. , 1978, Blood.

[8]  A. Haerer.  Citrate and alpha-ketoglutarate in cerebrospinal fluid and blood. , 1971, Neurology.

[9]  D. Mason,et al.  Kupffer cell staining by an HFE‐specific monoclonal antibody: implications for hereditary haemochromatosis , 1998, British journal of haematology.

[10]  W. Jefferies,et al.  Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease , 1999, Brain Research.

[11]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[12]  C. Cambiaso,et al.  The clinical relevance of ferritin concentration in the cerebrospinal fluid. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[13]  J. Connor,et al.  Variations in dietary iron alter brain iron metabolism in developing rats. , 2000, The Journal of nutrition.

[14]  Mark Hallett,et al.  Increased iron in the dentate nucleus of patients with Friedreich's ataxia , 1999, Annals of neurology.

[15]  A. Gocht,et al.  Changes in glial cell markers in recent and old demyelinated lesions in central pontine myelinolysis , 2004, Acta Neuropathologica.

[16]  J. Connor,et al.  Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. , 1997, The Journal of nutrition.

[17]  D. Mostofsky,et al.  Brain iron-deficiency causes reduced learning capacity in rats , 1986, Pharmacology Biochemistry and Behavior.

[18]  K. Earle.  Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.

[19]  Ferritin concentration in cerebrospinal fluid , 1985, Acta neurologica Scandinavica.

[20]  A. Jaworowski,et al.  Developmental patterns of gene expression of secreted proteins in brain and choroid plexus. , 1989, Developmental biology.

[21]  T. Moos.  Developmental profile of non-heme iron distribution in the rat brain during ontogenesis. , 1995, Brain research. Developmental brain research.

[22]  J. Connor,et al.  Expression of Transferrin mRNA in the CNS of Normal and Jimpy Mice , 1991, Journal of neurochemistry.

[23]  W. Pardridge,et al.  Human Blood—Brain Barrier Insulin Receptor , 1985, Journal of neurochemistry.

[24]  Kenneth F. Swaiman.  Hallervorden-Spatz syndrome and brain iron metabolism. , 1991 .

[25]  J. Connor,et al.  Iron and iron management proteins in neurobiology. , 2001, Pediatric neurology.

[26]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[27]  P. Gros,et al.  Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. , 1999, Blood.

[28]  J. Connor,et al.  Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains , 1999, Journal of the Neurological Sciences.

[29]  B. Hyman,et al.  Alzheimer's mutation , 1991, Nature.

[30]  W. Sly,et al.  Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis. , 2001, Gastroenterology.

[31]  J. Bulte,et al.  Microscopic R2* mapping of reduced brain iron in the Belgrade rat , 2002, Annals of neurology.

[32]  K. Dziegielewska,et al.  Proteins in cerebrospinal fluid and plasma of fetal pigs during development. , 1982, Developmental neuroscience.

[33]  S. LeVine,et al.  Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. , 1998, Life sciences.

[34]  R. Hider,et al.  Non‐transferrin‐bound iron is present in serum of hereditary haemochromatosis heterozygotes , 2000, European journal of clinical investigation.

[35]  W. Jefferies,et al.  Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium , 1996, Brain Research.

[36]  M. Núñez,et al.  HFE inhibits apical iron uptake by intestinal epithelial (Caco‐2) cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  A. Koeppen,et al.  Comparative immunocytochemistry of Pelizaeus-Merzbacher disease, the jimpy mouse, and the myelin-deficient rat , 1988, Journal of the Neurological Sciences.

[38]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[39]  J. Connor,et al.  Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome , 2000, Neurology.

[40]  W. Kuschinsky,et al.  Regional Congruence and Divergence of Glucose Transporters (GLUT1) and Capillaries in Rat Brains , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  R. Kalaria,et al.  Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease , 1992, Brain Research.

[42]  S. R. Snodgrass,et al.  Model for transport in the central nervous system. , 1977, The American journal of physiology.

[43]  A. F. Hearers.  Citrate and alpha‐ketoglutarate in cerebrospinal fluid and blood , 1971, Neurology.

[44]  E. Ling,et al.  Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. , 1994, Journal of anatomy.

[45]  J. Gitlin,et al.  Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Bartzokis,et al.  MR evaluation of age-related increase of brain iron in young adult and older normal males. , 1997, Magnetic resonance imaging.

[47]  C. Morris,et al.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease , 2001, Nature Genetics.

[48]  J. Connor,et al.  Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.

[49]  W. Pardridge,et al.  Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery , 1994, Pharmaceutical Research.

[50]  J. Connor,et al.  Aluminum access to the brain: a role for transferrin and its receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Tu,et al.  Iron Deficiency in two Adolescents with Conduct, Dysthymic and Movement Disorders , 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[52]  H. G. Eijk,et al.  Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[53]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[54]  W. Jefferies,et al.  Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin , 1996, Brain Research.

[55]  R. Simpson,et al.  Rate of 59Fe Uptake into Brain and Cerebrospinal Fluid and the Influence Thereon of Antibodies Against the Transferrin Receptor , 1993, Journal of neurochemistry.

[56]  G. Reynolds,et al.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain , 2005, Journal of Neural Transmission.

[57]  E. Morgan,et al.  Evidence for low molecular weight, non‐transferrin‐bound iron in rat brain and cerebrospinal fluid , 1998, Journal of neuroscience research.

[58]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[59]  R. Broadwell,et al.  Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood , 1976, The Journal of comparative neurology.

[60]  L. Fenart,et al.  Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.

[61]  P. Hof,et al.  Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease cases , 1996, Acta Neuropathologica.

[62]  R. Scott,et al.  Is hemochromatosis a risk factor for Alzheimer's disease? , 2001, Journal of Alzheimer's disease : JAD.

[63]  J. Gitlin,et al.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. , 1998, The American journal of clinical nutrition.

[64]  R. Fine,et al.  Receptor-mediated endocytosis of transferrin at the blood-brain barrier. , 1993, Journal of cell science.

[65]  G. Finocchiaro,et al.  High frequency of the H63D mutation of the hemochromatosis gene (HFE) in malignant gliomas , 2001, Neurology.

[66]  R. Fine,et al.  Development of transferrin‐positive oligodendrocytes in the rat central nervous system , 1987, Journal of neuroscience research.

[67]  B. Bacon,et al.  A 39-Year-Old Man with Chronic Hepatitis, Elevated Serum Ferritin Values, and a Family History of Hemochromatosis , 1993, Seminars in liver disease.

[68]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[69]  J. Connor,et al.  Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease , 1992, Journal of neuroscience research.

[70]  J. Cook,et al.  Iron deficiency: the global perspective. , 1994, Advances in experimental medicine and biology.

[71]  A. Deinard,et al.  Cognitive deficits in iron-deficient and iron-deficient anemic children. , 1986, The Journal of pediatrics.

[72]  B. N. Patel,et al.  A Novel Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin Is Expressed by Mammalian Astrocytes* , 1997, The Journal of Biological Chemistry.

[73]  D. Berg,et al.  The basal ganglia in haemochromatosis , 2000, Neuroradiology.

[74]  J. Valk,et al.  White matter disorders. , 1991, Current opinion in neurology and neurosurgery.

[75]  A. Warren,et al.  Are hereditary hemochromatosis mutations involved in Alzheimer disease? , 2000, American journal of medical genetics.

[76]  John Hardy,et al.  The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity , 2000, The Journal of Neuroscience.

[77]  J. Cook,et al.  Cerebrospinal fluid ferritin levels in screening for meningism. , 1986, Archives of neurology.

[78]  E. Morgan,et al.  Diminished iron acquisition by cells and tissues of Belgrade laboratory rats. , 1992, The American journal of physiology.

[79]  S. Powers,et al.  Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain , 1999, Journal of neurochemistry.

[80]  James R. Connor,et al.  Iron in the Brain: An Important Contributor in Normal and Diseased States , 2000 .

[81]  R. Switzer,et al.  The regional distribution and cellular localization of iron in the rat brain , 1984, Neuroscience.

[82]  Michael W. Miller,et al.  Iron Regulation in the Developing Rat Brain: Effect of In Utero Ethanol Exposure , 1995, Journal of neurochemistry.

[83]  N. Andrews,et al.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[84]  W. Sly,et al.  Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Connor,et al.  Oligodendrocyte progenitor cells internalize ferritin via clathrin‐dependent receptor mediated endocytosis , 2000, Journal of neuroscience research.

[86]  E. Morgan,et al.  Kinetics and distribution of [59Fe–125I]transferrin injected into the ventricular system of the rat , 1998, Brain Research.

[87]  W. Pardridge,et al.  The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier. , 1990, Biochemical and biophysical research communications.

[88]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[89]  R P Allen,et al.  MRI measurement of brain iron in patients with restless legs syndrome , 2001, Neurology.

[90]  J. Connor,et al.  Iron, Transferrin, and Ferritin in the Rat Brain During Development and Aging , 1994, Journal of neurochemistry.

[91]  J. Connor,et al.  Cellular distribution of iron, transferrin, and ferritin in the hypotransferrinemic (Hp) mouse brain , 1995, The Journal of comparative neurology.

[92]  B. Carroll,et al.  Serum Melanotransferrin, p97 as a Biochemical Marker of Alzheimer's Disease , 2001, Neuropsychopharmacology.

[93]  S. Lynch,et al.  Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients , 1999, Brain Research.

[94]  H. Palti,et al.  Learning achievement and behavior at school of anemic and non-anemic infants. , 1985, Early human development.

[95]  W. Banks,et al.  Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier , 1988, Brain Research Bulletin.

[96]  W. Pardridge,et al.  Human blood-brain barrier transferrin receptor. , 1987, Metabolism: clinical and experimental.

[97]  G. Bartzokis,et al.  Increased basal ganglia iron levels in Huntington disease. , 1999, Archives of neurology.

[98]  M. MacDonald,et al.  Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. , 2000, Human molecular genetics.

[99]  J. Connor,et al.  Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat , 2001, Journal of neuroscience research.

[100]  M. Cazzola,et al.  Cerebrospinal fluid ferritin in human disease. , 1986, Haematologica.

[101]  E. Thompson,et al.  Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[102]  Bernstein Se.  Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. , 1987 .

[103]  James R. Connor,et al.  Cellular management of iron in the brain , 1995, Journal of the Neurological Sciences.

[104]  P. Mantyh,et al.  Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.

[105]  H. Ranney,et al.  A THALASSEMIA‐LIKE DISORDER IN BELGRADE LABORATORY RATS * , 1969, Annals of the New York Academy of Sciences.

[106]  J. Lucas,et al.  Studies of the mechanism of iron transport across the blood‐brain barrier , 1992, Annals of neurology.

[107]  J. Connor,et al.  Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain , 1993, The Journal of comparative neurology.

[108]  J. Dobbing.  The development of the blood-brain barrier. , 1968, Progress in brain research.

[109]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[110]  Y Agid,et al.  Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Connor,et al.  Cellular distribution of iron in the brain of the Belgrade rat , 1999, Neuroscience.

[112]  J. Connor,et al.  Regional Variation in the Levels of Transferrin in the CNS of Normal and Myelin‐Deficient Rats , 1987, Journal of neurochemistry.

[113]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[114]  F. Bloom,et al.  Blood-brain barrier penetration and in vivo activity of an NGF conjugate. , 1993, Science.

[115]  D. Mash,et al.  Characterization and Distribution of Transferrin Receptors in the Rat Brain , 1990, Journal of neurochemistry.